237 related articles for article (PubMed ID: 20356942)
21. Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.
Autier P; Boniol M; Smans M; Sullivan R; Boyle P
PLoS One; 2016; 11(4):e0154113. PubMed ID: 27100174
[TBL] [Abstract][Full Text] [Related]
22. Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme.
Duffy SW; Sasieni P; Olsen AH; Cafferty FH
Stat Methods Med Res; 2010 Oct; 19(5):547-55. PubMed ID: 20130109
[TBL] [Abstract][Full Text] [Related]
23. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
[TBL] [Abstract][Full Text] [Related]
24. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
Duffy SW; Parmar D
Breast Cancer Res; 2013 May; 15(3):R41. PubMed ID: 23680223
[TBL] [Abstract][Full Text] [Related]
25. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
[TBL] [Abstract][Full Text] [Related]
26. Screening for breast cancer in England: past and future.
Advisory Committee on Breast Cancer Screening
J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
[TBL] [Abstract][Full Text] [Related]
27. Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.
Gunsoy NB; Garcia-Closas M; Moss SM
Br J Cancer; 2014 May; 110(10):2412-9. PubMed ID: 24762956
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
29. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
30. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
Jørgensen KJ; Zahl PH; Gøtzsche PC
BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
[TBL] [Abstract][Full Text] [Related]
31. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
Yen MF; Tabár L; Vitak B; Smith RA; Chen HH; Duffy SW
Eur J Cancer; 2003 Aug; 39(12):1746-54. PubMed ID: 12888370
[TBL] [Abstract][Full Text] [Related]
32. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
[TBL] [Abstract][Full Text] [Related]
33. Screening for breast cancer with mammography.
Gøtzsche PC; Nielsen M
Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
[TBL] [Abstract][Full Text] [Related]
34. Screening for breast cancer with mammography.
Gøtzsche PC; Nielsen M
Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
[TBL] [Abstract][Full Text] [Related]
35. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
36. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
38. Screening for breast cancer with mammography.
Gøtzsche PC; Nielsen M
Cochrane Database Syst Rev; 2006 Oct; (4):CD001877. PubMed ID: 17054145
[TBL] [Abstract][Full Text] [Related]
39. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?
Duffy SW; Tabar L; Vitak B; Warwick J
Breast J; 2006; 12 Suppl 1():S91-5. PubMed ID: 16430402
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.
Allgood PC; Warwick J; Warren RM; Day NE; Duffy SW
Br J Cancer; 2008 Jan; 98(1):206-9. PubMed ID: 18059396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
